tirzépatide prix Alors intéressant ou pas ces nouveaux tarifs ?😶🙌🏾, #mounjaro #obésité #pertedepoids #glp1 #wegovy Welcome to Mounjaro® (tirzepatide injection)

Lee et al

Nonalcoholic steatohepatitis is the most common cause of chronic liver disease in the western countries (up to 24% of all patients with liver disease), with 75% of those with NASH being classified as obese (1)

Weight loss drugs like semaglutide works by mimicking GLP-1, a hormone your body naturally produces to regulate blood sugar, control appetite, and boost metabolism

As its use has expanded, questions have emerged about potential side effects, including concerns about semaglutide and blood clots

FDA Access Data+1 Reduce the risk of major cardiovascular events in adults with obesity or overweight and established cardiovascular disease, based largely on the SELECT cardiovascular outcomes trial